ANVS Insider Trading Activity and SEC Form 4 Filings
ANVS insider trading summary
Over the past 12 months, insiders at Annovis Bio, Inc. (ANVS) reported 14 open-market purchases worth $7.1M by 1 insider and no sales on SEC Form 4. Net insider buying was $7.1M.
Latest ANVS insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 6, 2026 | Michael B Hoffman | Director | Buy | $5.0M (5,000,000 @ $1.00) |
| May 20, 2026 | Michael B Hoffman | Director | Buy | $4K (2,562 @ $1.75) |
| May 20, 2026 | Michael B Hoffman | Director | Buy | $34K (18,849 @ $1.80) |
| May 20, 2026 | Michael B Hoffman | Director | Buy | $104K (54,933 @ $1.90) |
| Apr 2, 2026 | Michael B Hoffman | Director | Buy | $1.5M (713,800 @ $2.10) |
| Dec 8, 2025 | Michael B Hoffman | Director | Buy | $64K (15,000 @ $4.24) |
| Dec 8, 2025 | Michael B Hoffman | Director | Buy | $130K (30,000 @ $4.34) |
| Nov 24, 2025 | Michael B Hoffman | Director | Buy | $117K (28,096 @ $4.15) |
| Nov 24, 2025 | Michael B Hoffman | Director | Buy | $2K (415 @ $4.14) |
| Nov 24, 2025 | Michael B Hoffman | Director | Buy | $6K (1,489 @ $4.13) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.